Nature of the Business and Basis of Presentation - Schedule of Reverse Capitalization (Details) - USD ($) $ in Thousands					12 Months Ended
	Nov. 09, 2023	Oct. 20, 2023	Jun. 10, 2021	Jun. 09, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reverse Capitalization, Value [Abstract]
PIPE and SPAC financing					$ 51,998	$ 16,824	$ 1
Reverse recapitalization							251,235
Additional Paid-In Capital
Reverse Capitalization, Value [Abstract]
Redemption of Class H units			$ (900)
PIPE and SPAC financing			377,654		$ 45,475	$ 16,824	(344)
Earn-out liability			(119,759)
Transaction expenses			(21,575)
Warrants liability			(74,408)
Reverse recapitalization			251,229				$ 251,229
Embry Convertible Subordinated Notes Payable | Convertible debt | Additional Paid-In Capital
Reverse Capitalization, Value [Abstract]
Embry notes conversion			4,118
Public Warrants | Additional Paid-In Capital
Reverse Capitalization, Value [Abstract]
Embry notes conversion			0
Securities Subject to Mandatory Redemption | Additional Paid-In Capital
Reverse Capitalization, Value [Abstract]
Embry notes conversion			$ 86,099
Class A
Reverse Capitalization, Shares [Abstract]
SAFEs converted into Class A units (in shares)				284,925
PIPE and SPAC financing (in shares)	703,175	7,027,517
Class A | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
Redemption of shares (in shares)			(125,101)
PIPE and SPAC financing (in shares)		7,027,517	44,797,894		5,219,500	2,131,759	1,725,000
Reverse recapitalization (in shares)			60,441,289				60,441,289
Reverse Capitalization, Value [Abstract]
PIPE and SPAC financing			$ 4				$ 1
Reverse recapitalization			$ 6				$ 6
Class A | Embry Convertible Subordinated Notes Payable | Convertible debt | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
SAFEs converted into Class A units (in shares)			8,023,072
Reverse Capitalization, Value [Abstract]
Embry notes conversion			$ 1
Class A | Public Warrants | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
SAFEs converted into Class A units (in shares)			278,533
Class A | Securities Subject to Mandatory Redemption | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
SAFEs converted into Class A units (in shares)			7,466,891
Reverse Capitalization, Value [Abstract]
Embry notes conversion			$ 1
Class V | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
Reverse recapitalization (in shares)			454,077				454,077
Reverse Capitalization, Value [Abstract]
Reverse recapitalization			$ 0
Class V | Securities Subject to Mandatory Redemption | Purchase price — equity consideration issuable (common stock)
Reverse Capitalization, Shares [Abstract]
SAFEs converted into Class A units (in shares)			454,077